Article info

Download PDFPDF
Letter
Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B

Authors

  1. Correspondence to Dr Faisal Kamal, University of Tennessee Health Science Center, Memphis, TN 38163, USA; fkamal36{at}gmail.com
View Full Text

Citation

Kamal F, Khan MA, Ahmed A, et al
Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B

Publication history

  • Received December 24, 2019
  • Revised January 21, 2020
  • Accepted January 31, 2020
  • First published February 10, 2020.
Online issue publication 
October 07, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.